Who We Are

• Located in Philadelphia, Pennsylvania
• CLIA certified and CAP accredited
• Advanced pipetting and robotic systems
• Custom designed workflows to meet your needs

Drexel Medical Diagnostics is a CLIA- and CAP-accredited laboratory located in the heart of Philadelphia, Pennsylvania. Through the use of advanced pipetting and robotics systems, we can customize design workflows to meet your needs. Drexel Medical Diagnostics’ laboratory is backed by the research and development expertise of the Department of Microbiology and Immunology and the Institute for Molecular Medicine and Infectious Disease at Drexel University College of Medicine.

Why Drexel Medicine Diagnostics

• Drexel Medicine Diagnostics offers a range of in-demand testing services to support your needs — from microbiology, toxicology screens, viral and bacterial testing including tick-borne diseases, to COVID-19.
• We are committed to speed, precision and customer service. Our automated capabilities ensure fast turnaround times and more accurate test results.
• Understanding the mechanisms of disease and the development of strategies to prevent and treat illnesses through scientific discovery are paramount to us.
• As part of Drexel University College of Medicine, Drexel Medicine Diagnostics provides the opportunity to partner with expert researchers and supports the continuous development of cutting-edge diagnostics in genomics, toxicology, clinical chemistry, therapeutic drug monitoring and molecular diagnostics.

Accreditations

Leadership

Garth Ehrlich, PhD, FAAAS, FAAM

Technical Director

Dr. Ehrlich earned his PhD from Syracuse University in 1987 and is a professor of microbiology and immunology and otolaryngology-head and neck surgery at Drexel University College of Medicine. He is the executive director of three Research Centers of Excellence in the Institute for Molecular Medicine and Infectious Diseases and is the editor-in-chief of Genetic Testing and Molecular Biomarker.

Cheryl Hanau, MD

Medical Director

Dr. Hanau earned her MD from Jefferson Medical College in 1989 and has a focus on cytopathology. She is a professor and the Richard Shuman, MD, Chair of the Department of Pathology & Laboratory Medicine at Drexel University College of Medicine. Before her appointment as chair, Dr. Hanau served the College of Medicine in a number of other key positions, most recently as associate dean for admissions and program director of the Pathology and Laboratory Medicine Residency. Dr. Hanau has been named as a “Top Doctor” by Philadelphia Magazine.

Yinghua Qiu, PhD, DABCC

Associate Medical Director

Dr. Qiu obtained her PhD in Analytical Chemistry from the University of Michigan in 2008. After completing her PhD, she undertook a two-year fellowship at the University of Texas Medical Branch in Clinical Chemistry and became a board-certified clinical chemist by the ABCC during her fellowship training in 2010. Her professional expertise spans several domains of clinical practice, encompassing clinical chemistry, clinical toxicology, therapeutic drug monitoring, molecular microbiology, as well as applying mass spectrometry in clinical settings and conducting basic research in proteomics.

Donald Hall, PhD

Operations Director

Dr. Hall earned his PhD in medicinal chemistry from Drexel University in 2020 and is currently the operations director of Drexel Medicine Diagnostics, as well as an assistant professor in the Department of Microbiology and Immunology. He completed a post-doctoral fellowship focusing on microbiology and molecular biology at Drexel College of Medicine. Dr. Hall's lab specializes in researching anti-biofilm agents for the treatment of persistent infections and the in-silico development of novel compounds targeting the bacterial stringent response.

Brian Wigdahl, PhD

Chair, Department of Microbiology and Immunology

Dr. Wigdahl earned his PhD from the Medical College of Wisconsin in 1980 and is professor and chair of the Department of Microbiology and Immunology at Drexel University College of Medicine. His research is in immunopathogenesis and neuropathogenesis of HIV-1 and HTLV-I infection as well as transcriptional regulation of retroviral expression.

Jim Sapienza, FACHE

Chief Clinical Officer

Mr. Sapienza earned a master’s degree in business administration and a master’s degree in health administration from the University of Minnesota. He leads the medical clinics for Drexel Medicine and oversees the operations, strategy and business development for Drexel Medicine Diagnostics.

The information on these pages is provided for general information only and should not be used for diagnosis or treatment, or as a substitute for consultation with a physician or health care professional. If you have specific questions or concerns about your health, you should consult your health care professional.

The images being used are for illustrative purposes only; any person depicted is a model.

 
 Back to Top